IAS
IMA Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,500
| Closed | -$133K | – | 300 |
|
|
2021
Q4 | $133K | Sell |
1,500
-32,048
| -96% | -$2.84M | 0.03% | 143 |
|
|
2021
Q3 | $2.59M | Buy |
33,548
+1,092
| +3% | +$84.4K | 0.61% | 57 |
|
|
2021
Q2 | $2.71M | Sell |
32,456
-426
| -1% | -$35.5K | 0.63% | 57 |
|
|
2021
Q1 | $2.48M | Buy |
32,882
+7,350
| +29% | +$555K | 0.61% | 65 |
|
|
2020
Q4 | $2.24M | Sell |
25,532
-8,553
| -25% | -$750K | 0.63% | 58 |
|
|
2020
Q3 | $2.59M | Buy |
34,085
+5,151
| +18% | +$392K | 0.87% | 36 |
|
|
2020
Q2 | $3.57M | Sell |
28,934
-10,298
| -26% | -$1.27M | 1.29% | 22 |
|
|
2020
Q1 | $3.32M | Sell |
39,232
-2,008
| -5% | -$170K | 1.46% | 17 |
|
|
2019
Q4 | $3.49M | Buy |
41,240
+521
| +1% | +$44.1K | 1.29% | 22 |
|
|
2019
Q3 | $2.74M | Buy |
40,719
+3,353
| +9% | +$226K | 1.04% | 35 |
|
|
2019
Q2 | $3.2M | Sell |
37,366
-2,293
| -6% | -$196K | 1.2% | 29 |
|
|
2019
Q1 | $3.52M | Buy |
39,659
+704
| +2% | +$62.5K | 1.37% | 21 |
|
|
2018
Q4 | $3.32M | Buy |
38,955
+941
| +2% | +$80.1K | 1.55% | 15 |
|
|
2018
Q3 | $3.69M | Buy |
38,014
+2,876
| +8% | +$279K | 1.44% | 18 |
|
|
2018
Q2 | $3.31M | Buy |
35,138
+417
| +1% | +$39.3K | 1.38% | 19 |
|
|
2018
Q1 | $2.82M | Buy |
+34,721
| New | +$2.82M | 1.25% | 24 |
|